$CAC

Camden National Q2 Earnings Call Highlights

Camden National (NASDAQ:CAC) Q2 earnings call covered loan and deposit trends and guidance. Archer said quarterly cash flows modeled at about $35M from investments and $170M to $180M from loans, with new loan pricing in the low-6% to 6.5% range. Noninterest income rose 21% to $14.5M; Q3 outlook $13.5M to $14M. Assets were $7B; deposits $5.6B; tangible book value per share $31.64.

Original reporting
Published Jul 30, 2026, 8:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 30, 2026, 8:55 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Camden National Q2 Earnings Call Highlights — source image
Decision brief

The 30-second read

$CACNeutralMed
01

Why it matters

Traders can use the stated loan origination pricing range and Q3 noninterest income and expense expectations to update near-term earnings and margin scenarios, while credit metrics and net charge-offs inform downside risk.

02

Market read

This is a guidance-heavy earnings-call recap with actionable inputs for Q3 modeling: loan pricing (low-6% to 6.5%), noninterest income ($13.5M to $14.0M), and noninterest expense ($37M to $38M).

03

What to watch

The article emphasizes pricing and fee income but does not quantify net interest income or deposit cost changes, which are key to translating loan pricing into earnings power.

Relevance 7/10Novelty 6/10Timing: pre-market today, ahead of trader positioning for Q3 guidance and loan-pricing sensitivity

Background

The piece summarizes Camden National’s Q2 earnings call Q&A, focusing on guidance for noninterest income/expense, loan pipeline, deposit strategy, credit quality, and capital returns.

Company-level read

Ticker impact

$CACNeutralMedium confidence
Context

Camden National’s Q2 call highlights include loan pricing guidance (low-6% to 6.5%), noninterest income/expense outlook, and credit metrics.

Expected impact

Likely modest post-earnings volatility, with focus on net interest sensitivity to the stated low-6% to 6.5% loan pricing and the Q3 noninterest income/expense range.

Evidence & confidence

The article provides multiple forward-looking datapoints (Q3 noninterest income and expense ranges, loan growth expectations) plus current credit and capital return figures, but it lacks a full earnings table or explicit EPS/consensus comparison.

Market effects

Provides a community-bank read-through on loan yield (low-6% to 6.5% pricing) and deposit mix strategy, relevant for regional bank margin expectations.

Primarily impacts sentiment around Maine/New England community banking and mortgage-linked lending demand.

Low; this is company-specific earnings guidance with limited cross-market spillover.

Counterpoint

Measured loan growth despite a 45% jump in committed pipeline could signal cautious demand or underwriting constraints, limiting upside from volume growth.

Key entities

  • Camden National Corporation

    NASDAQ-listed community bank; Q2 call highlights include loan pricing, fee income outlook, credit metrics, and capital return activity.

  • Camden National Bank

    Primary operating subsidiary referenced for lending and deposit products.

Related articles

Med

Camden National Corporation Q2 2026 Earnings Call Summary

Camden National Corporation reported record Q2 2026 net income of $23 million, citing loan growth, a 2 bp net interest margin expansion from lower funding costs and deposit mix, and 21% linked-quarter fee income growth. HELOC balances rose 23% YoY, and management expects Q3 NIM up 5 to 10 bp, noninterest income $13.5m to $14m, and expenses $37m to $38m.

$CACMedAI 8/10

Camden National Corporation Reports Record Quarterly Net Income of $23.0 Million and Diluted EPS of $1.35 for the Second Quarter of 2026

Camden National Corporation (NASDAQ: CAC) reported Q2 2026 net income of $23.0 million and diluted EPS of $1.35 for the quarter ended June 30, 2026. For the first six months, net income was $44.9 million and diluted EPS $2.64. The company cited 3% annualized loan growth, net interest margin at 3.26%, and a $0.42/share dividend, plus a Q2 buyback of 52,000 shares.

$USNAHighAI 9/10

Why Usana Health Sciences Stock Plummeted This Week

Usana Health Sciences (USNA) shares fell about 30% after its Aug. 4 Q2 results missed expectations and guidance disappointed. The company reported non-GAAP EPS of $0.07 on about $223M sales, with sales and profit below analyst averages. It also took a $29M goodwill impairment on Hiya, cut 2024 guidance to an $11M loss and lowered sales to $910M from $925M-$1B.